BAX

#753
Baxter International Inc.
20.42
-0.44%
Sector:
Básica:
Profit Currency:
Rango diario
20.25
20.49
Rango anual
17.40
37.74
Cambio diario
-0.44%
Monthly Change
+4.29%
6 month change
-16.62%
Cambio anual
-41.57%
Cierres anteriores
20.51
Open
20.26
Bid
Ask
Low
20.25
High
20.49
Volumen
4 035
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 10.48 B
  • Employee 38 K
  • Founded N/A
  • CEO Andrew Hider
  • Website www.baxter.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCVJ77
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.22
Price to sales ratio
0.87
Dividends per share
0.01
Dividend yield %
2.72

Baxter International Inc

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

Noticias